Adam S. Levy's most recent trade in Mineralys Therapeutics Inc was a trade of 10,758 Common Stock done at an average price of $32.1 . Disclosure was reported to the exchange on Jan. 12, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Mineralys Therapeutics Inc | Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 32.14 per share. | 12 Jan 2026 | 10,758 | 8,638 | - | 32.1 | 345,723 | Common Stock |
| Mineralys Therapeutics Inc | Adam S. Levy | CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.25 per share. | 11 Nov 2025 | 44,079 | 132,307 | - | 14.3 | 628,126 | Common Stock |
| Mineralys Therapeutics Inc | Adam S. Levy | CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2025 | 44,079 | 91,592 | - | - | Stock Option | |
| Mineralys Therapeutics Inc | Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 45.93 per share. | 11 Nov 2025 | 38,900 | 52,114 | - | 45.9 | 1,786,588 | Common Stock |
| Mineralys Therapeutics Inc | Adam S. Levy | CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.00 per share. | 11 Nov 2025 | 34,414 | 88,228 | - | 16 | 550,624 | Common Stock |
| Mineralys Therapeutics Inc | Adam S. Levy | CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2025 | 34,414 | 20,662 | - | - | Stock Option | |
| Mineralys Therapeutics Inc | Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 46.88 per share. | 11 Nov 2025 | 32,718 | 19,396 | - | 46.9 | 1,533,977 | Common Stock |
| Mineralys Therapeutics Inc | Adam S. Levy | CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.20 per share. | 11 Nov 2025 | 20,547 | 53,814 | - | 10.2 | 209,579 | Common Stock |
| Mineralys Therapeutics Inc | Adam S. Levy | CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2025 | 20,547 | 135,674 | - | - | Stock Option | |
| Mineralys Therapeutics Inc | Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 41.65 per share. | 11 Nov 2025 | 12,952 | 112,097 | - | 41.7 | 539,479 | Common Stock |
| Mineralys Therapeutics Inc | Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 41.87 per share. | 11 Nov 2025 | 11,295 | 126,610 | - | 41.9 | 472,932 | Common Stock |
| Mineralys Therapeutics Inc | Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 42.34 per share. | 11 Nov 2025 | 8,485 | 103,612 | - | 42.3 | 359,258 | Common Stock |
| Mineralys Therapeutics Inc | Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 45.18 per share. | 11 Nov 2025 | 8,456 | 91,014 | - | 45.2 | 382,046 | Common Stock |
| Mineralys Therapeutics Inc | Adam S. Levy | CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.44 per share. | 11 Nov 2025 | 6,613 | 138,920 | - | 15.4 | 102,105 | Common Stock |
| Mineralys Therapeutics Inc | Adam S. Levy | CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2025 | 6,613 | 4,888 | - | - | Stock Option | |
| Mineralys Therapeutics Inc | Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 43.50 per share. | 11 Nov 2025 | 4,142 | 99,470 | - | 43.5 | 180,183 | Common Stock |
| Mineralys Therapeutics Inc | Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 42.68 per share. | 11 Nov 2025 | 1,561 | 125,049 | - | 42.7 | 66,623 | Common Stock |
| Mineralys Therapeutics Inc | Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 42.00 per share. | 11 Nov 2025 | 1,015 | 137,905 | - | 42 | 42,630 | Common Stock |
| Mineralys Therapeutics Inc | Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 41.90 per share. | 13 Oct 2025 | 7,366 | 120,257 | - | 41.9 | 308,651 | Common Stock |
| Mineralys Therapeutics Inc | Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 42.26 per share. | 13 Oct 2025 | 3,392 | 116,865 | - | 42.3 | 143,333 | Common Stock |
| Mineralys Therapeutics Inc | Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 14.70 per share. | 28 Jul 2025 | 51,500 | 141,359 | - | 14.7 | 757,168 | Common Stock |
| Mineralys Therapeutics Inc | Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 14.04 per share. | 28 Jul 2025 | 12,946 | 193,666 | - | 14.0 | 181,803 | Common Stock |
| Mineralys Therapeutics Inc | Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 15.10 per share. | 28 Jul 2025 | 8,425 | 132,934 | - | 15.1 | 127,203 | Common Stock |
| Mineralys Therapeutics Inc | Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 14.00 per share. | 28 Jul 2025 | 807 | 192,859 | - | 14.0 | 11,302 | Common Stock |
| Mineralys Therapeutics Inc | Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 14.45 per share. | 11 Jul 2025 | 10,758 | 206,612 | - | 14.5 | 155,454 | Common Stock |
| Mineralys Therapeutics Inc | Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 12.06 per share. | 11 Apr 2025 | 10,757 | 215,340 | - | 12.1 | 129,684 | Common Stock |
| Mineralys Therapeutics Inc | Adam S. Levy | CFO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 170,000 | 170,000 | - | - | Stock Option | |
| Mineralys Therapeutics Inc | Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 9.09 per share. | 13 Jan 2025 | 10,657 | 226,197 | - | 9.1 | 96,901 | Common Stock |
| Mineralys Therapeutics Inc | Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 9.63 per share. | 13 Jan 2025 | 100 | 226,097 | - | 9.6 | 963 | Common Stock |
| Mineralys Therapeutics Inc | Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 13.57 per share. | 11 Oct 2024 | 10,757 | 236,854 | - | 13.6 | 146,004 | Common Stock |
| Mineralys Therapeutics Inc | Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 13.14 per share. | 11 Jul 2024 | 10,757 | 247,611 | - | 13.1 | 141,394 | Common Stock |
| Mineralys Therapeutics Inc | Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 12.94 per share. | 11 Jun 2024 | 96,815 | 255,462 | - | 12.9 | 1,252,718 | Common Stock |
| Mineralys Therapeutics Inc | Adam S. Levy | CFO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 200,000 | 200,000 | - | - | Stock Option | |
| Mineralys Therapeutics Inc | Adam S. Levy | CFO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 20,000 | 20,000 | - | - | Stock Option | |
| Mineralys Therapeutics Inc | Adam S. Levy | CFO, Chief Bus. Off. and Secy. | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 14 Feb 2023 | 6,250 | 350,811 | - | 16 | 100,000 | Common Stock |
| Mineralys Therapeutics Inc | Adam S. Levy | CFO, Chief Bus. Off. and Secy. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 97,518 | 97,518 | - | - | Stock Option |